medicare coverage for tirzepatide to Cover Blockbuster Obesity Drugs President Trump announced that Medicare

The new oral Wegovy option addresses a real barrier for patients with needle aversion, though it requires daily administration according to prescribing information rather than once-weekly dosing

doi: 10.1016/j.envpol.2021.116917 29 WangWZhouRRuanYFanS

Key Points Tirzepatide (Mounjaro/Zepbound) works differently than semaglutide (Ozempic/Wegovy) by targeting two hormones instead of one Studies show tirzepatide typically leads to greater weight loss (15-20% vs 8-10%) and better blood sugar control than semaglutide Switching is generally straightforward you can finish your semaglutide dose and start tirzepatide about a week later on your normal dose day Most people start at a lower tirzepatide dose (2.5mg or 5mg) even if they were on a high dose of semaglutide Thinking about making the switch from semaglutide (Ozempic or Wegovy) to tirzepatide (Mounjaro or Zepbound)

If you refill your medicine and it looks different, check with your pharmacist

Dose Response in Burns Interestingly, BPC-157 demonstrates effectiveness across a remarkably wide dose range in burn models

However, it became widespread for another reason